bpc-157 clinical trials human 2025 If worked as well as the internet says it does… …we'd probably have high quality by now. Instead we have... Lots of rat studies. Lots of podcasts. Lots of dihexa clinical trials humans Sublingual
Description
BPC-157 has been investigated in several different indications, and treatments, including gastrointestinal ulceration, bone healing, muscle healing, and central nervous system impairments, such as brain lesions, spinal cord injury, and behavioral disorders
Reported symptoms include headache, nausea, diarrhea, facial flushing, and in rare cases, skin rash or tingling
It facilitates quicker muscle recovery and provides neuroprotective effects by safeguarding mitochondria from oxidative damage
Kim, E.Y., Rajasekaran, G., and Shin, S.Y., Eur
